ABL1 and chronic myelogenous leukemia, BCR-ABL1 positive: We find that loss or haploinsufficiency of Tgif1 accelerates leukaemia development and shortens survival time in mouse models of MLL‐AF9‐induced AML and BCR‐ABL‐induced CML.